Arkolith/Insider Trading/SPRO/Form 4

Rajavelu Esther

CFO & CBOSpero Therapeutics, Inc. (SPRO) · full profile →Form 4 · filed Feb 5, 2025
Net Selling
Open-Market Buys
$0
Open-Market Sells
$16K
Net Open-Market Flow
-$16K
Transactions
3
3 non-derivative · 0 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Feb 5, 2025Sell(S)21K$0.78$16K725K
Feb 3, 2025Grant(A)100K—$0745K
Feb 3, 2025Grant(A)266K—$0645K

Transaction Codes

S
Open-market sale
A
Grant / award

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0000950170-25-014859) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML